Population: Adults without known dyslipidemia.
Organizations
Screening Recommendations
Screen all adults within recommended age range.
Use lipid data to determine risk score (ie, ASCVD risk calculator: https://tools.acc.org/ascvd-risk-estimator-plus) to determine need for primary prevention.
Use lipid data, other levels (FPG/HgbA1c, eGFR), with Framingham Risk Score (FRS) or the Cardiovascular Life Expectancy Model (CLEM) to determine need for primary prevention. (CCS)
Consider screening adults regardless of age with other risk factors (clinical evidence of atherosclerosis, abdominal aortic aneurysm, diabetes mellitus, arterial hypertension , cigarette smoking, stigmata of dyslipidemia-corneal arcus, xanthelasma, xanthoma), family history of premature CVD or dyslipidemia, CKD (eGFR ≤ 60 mL/min/1.73 m2), BMI ≥ 30, inflammatory diseases (RA, SLE, PsA, AS, IBD), HIV infection, erectile dysfunction, COPD, history of hypertensive disorder of pregnancy. (CCS)
Sources
VA/DoD Clinical Practice Guideline for the Management of Dyslipidemia for Cardiovascular Risk Reduction. June 2020.
JAMA. 2016;316(19):1997-2007.
Circulation. 2019;139:e1046-e1081.
Can J Cardiol. 2021 Aug;37(8):1129-1150.
Endocr Pract. 2017 Apr;23(Suppl 2).